Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
850people in the Nephropathy in Type 2 Diabetes trial, from 2005
564of them with cardiovascular disease, in this paper
Already taking HbA1c, or nottheir own situation, not assigned
on HbA1c
not on HbA1c
HbA1c went with higher major heart events+20%
correlation, not a testthe abstract, start to end
… of MACE between the two groups (HR 1.201, CI 1.041-1.387, p 0.012).
← favours treatmentfavours comparator →
could be chanceMACEHbA1c
HR 1.2011.04–1.39
StatinsCardiovascular events
1 / 4